Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, View ORCID ProfileJacques Turgeon
doi: https://doi.org/10.1101/2020.04.21.20066761
Veronique Michaud
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Operating Officer
Pamela Dow
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
MSRoles: Clinical Research Manager
Sweilem B. Al Rihani
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmD, PhDRoles: Clinical Research Scientist
Malavika Deodhar
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Clinical Research Scientist
Meghan Arwood
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmDRoles: Clinical Research Scientist
Brian Cicali
2University of Florida Center for Pharmacometrics and Systems Pharmacology, 6550 Sanger Road, Orlando, FL 32827
MScRoles: PhD Student, Pharmaceutics
Jacques Turgeon
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Scientific Officer
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials.
Posted April 29, 2020.
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2340)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11707)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3692)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2372)
- Health Policy (927)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3456)
- Nursing (195)
- Nutrition (520)
- Oncology (1804)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6093)
- Radiology and Imaging (1261)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)